Global Transdermal Patches Market is expected to reach USD 7383.47 Billion by 2026 from USD 4445.18 Billion in 2017 at a CAGR of 5.8%. The upcoming market report contains data for historic year 2017, base year for this study is 2018 and the forecast period is 2019–2026. The rising number of diabetic patients across the globe is likely to increase the consumption of transdermal drug delivery patch.
According to WHO, in the year 2017, the number of people suffering from diabetes globally was about 422 million.
Want to Know More | Get FREE Sample Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-transdermal-patches-market
Key Market Competitors: Global Transdermal Patches Market
Few of the major competitors currently working in the Transdermal Patches Market are AdhexPharma, ProSolus, Inc., Tapemark, Tesa Labtec GmbH, Nitto Denko Corporation, Noven Pharmaceuticals, Inc. (Wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc.), LTS Lohmann, Therapie-Systeme AG, Medherant Limited, Corium International, Inc., Bayer AG, ANI Pharmaceuticals Inc., Novartis AG, Janssen Pharmaceuticals Inc., Antares Pharma Inc., Aneva Drug Delivery Systems, Abbott Laboratories, Medipatch, Inc., Mylan Pharmaceutical, Inc., Acrux Limited among others.
Key Developments in the Market:
In December 2018, Hisamitsu Pharmaceutical Co., Inc. (Japan) announced that the transdermal, pain management patch FENTOSTAPE achieved the primary endpoint of the Phase III clinical study in Japan.
In July 2018, Mylan N.V. (U.S.) launched generic version of Novartis’ Exelon Patch known as Rivastigmine Transdermal System for the treatment of patients suffering from dementia in the US.
Increasing advantages over the oral and ingesting medications is expected to drive the market growth
Non-Invasive and painless administration of medication is also expected to drive the market growth
Inability of the skin to absorb large range of medications is expected to restrain the market growth
Development of contact dermatitis or other skin infections at the site of application is also expected to restrain the market growth
Download Free | Toc at https://databridgemarketresearch.com/toc/?dbmr=global-transdermal-patches-market
Segmentation: Global Transdermal Patches Market
Cardiovascular, CNS, Pain Management, Dermatology, Others
Electric current, Mechanical arrays, Thermal Ablation, Chemical Enhancers, Others
Middle East and Africa
Some of the Major Highlights of TOC covers:
Chapter 1: Methodology & Scope
Definition and forecast parameters
Methodology and forecast parameters
Chapter 2: Executive Summary
Chapter 3: Transdermal Patches Industry Insights
Technological and innovation landscape
Chapter 4: Transdermal Patches Market, By Region
Chapter 5: Company Profile
This report is available at instant 10% discount for a limited time only:https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-transdermal-patches-market
Key Reasons to Purchase:
To gain insightful analyses of the market and have comprehensive understanding of the Global Transdermal Patches Market and its commercial landscape
Assess the Transdermal Patches production processes, major issues, and solutions to mitigate the development risk
To understand the most affecting driving and restraining forces in the Transdermal Patches Market and its impact in the Global market
Learn about the market strategies that are being adopted by leading respective organizations
To understand the future outlook and prospects for Global Transdermal Patches Market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research